|Seed, 12/09 |
Perfuzia Medical is developing the next generation of medical devices for the treatment of chronic wounds.
Bringing together the best in cutting edge science and engineering, Perfuzia is developing ActiveFlowTM - a non-biologic, non-invasive medical device harnessing the therapeutic stimulation of blood flow to transform the way chronic wounds are treated and managed.
With over 30 million patients around the world and annual spending in excess of $20 billion in the US alone, Pefuzia is addressing the fastest growing segment within this market.
By enabling and accelerating healing we aim to bring better care to patients around the world and reduce human suffering and healthcare costs associated with these conditions.